Skip to main content
SpringerLink
Log in

Neoadjuvante Kurzzeitradiotherapie gefolgt von FOLFOX-Chemotherapie

Kein Standardschema beim Rektumkarzinom

Neoadjuvant short-term radiotherapy followed by FOLFOX chemotherapy

No standard treatment for rectal cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223

    Article  CAS  PubMed  Google Scholar 

  2. Ngan SY, Burmeister B, Fisher RJ et al (2012) Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 30:3827–3833

    Article  PubMed  Google Scholar 

  3. Pettersson D, Lörinc E, Holm T et al (2015) Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer. Br J Surg 102:972–978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Breugom AJ, Swets M, Bosset J‑F et al (2015) Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16:200–207

    Article  CAS  PubMed  Google Scholar 

  5. Rödel C, Graeven U, Fietkau R et al (2015) Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 16:979–989

    Article  PubMed  Google Scholar 

  6. Schrag D, Weiser MR, Goodman KA et al (2014) Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 32:513–518

    Article  CAS  PubMed  Google Scholar 

  7. Deng Y, Chi P, Lan P et al (2016) Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol 34:3300–3307

    Article  PubMed  Google Scholar 

  8. García-Aguilar J, Chow OS, Smith DD et al (2015) Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16:957–966

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shin SJ, Yoon HI, Kim NK et al (2011) Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol 6:99

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. RadioOnkologie und Strahlentherapie, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    David Krug &  Matthias F. Häfner

Authors
  1. David Krug
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias F. Häfner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Krug.

Ethics declarations

Interessenkonflikt

D. Krug und M.F. Häfner geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krug, D., Häfner, M.F. Neoadjuvante Kurzzeitradiotherapie gefolgt von FOLFOX-Chemotherapie. Strahlenther Onkol 192, 951–953 (2016). https://doi.org/10.1007/s00066-016-1061-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1061-1

Search

Navigation